Precigen, Inc. (PGEN)
Largest Insider Buys in Sector
PGEN Stock Price History Chart
PGEN Stock Performance
About Precigen, Inc.
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional …
Insider Activity of Precigen, Inc.
Over the last 12 months, insiders at Precigen, Inc. have bought $20.19M and sold $136,327 worth of Precigen, Inc. stock.
On average, over the past 5 years, insiders at Precigen, Inc. have bought $22.84M and sold $10.09M worth of stock each year.
Highest buying activity among insiders over the last 12 months: KIRK RANDAL J () — $181.23M. Perez Jeffrey Thomas (SVP, IP Affairs) — $50,000.
The last purchase of 23,529,411 shares for transaction amount of $20M was made by KIRK RANDAL J () on 2024‑08‑09.
List of Insider Buy and Sell Transactions, Precigen, Inc.
| 2024-08-09 | 23.53M 7.203% | $0.85 | $20M | -16.04% | ||||
| 2024-08-09 | SVP, IP Affairs | 58,823 0.018% | $0.85 | $50,000 | -16.04% | |||
| 2023-12-28 | Sale | director | 96,686 0.039% | $1.41 | $136,327 | -1.96% | ||
| 2023-12-28 | 96,686 0.039% | $1.41 | $136,327 | -1.96% | ||||
| 2023-09-22 | director | 25,000 0.0099% | $1.41 | $35,250 | -2.86% | |||
| 2023-08-25 | Sale | President and CEO | 76,969 0.0243% | $1.53 | $117,763 | -19.65% | ||
| 2023-08-24 | Sale | SVP, IP Affairs | 8,891 0.0034% | $1.64 | $14,581 | -9.15% | ||
| 2023-08-24 | Sale | Chief Legal Officer | 10,947 0.0042% | $1.64 | $17,953 | -9.15% | ||
| 2023-08-24 | Sale | Chief Financial Officer | 9,045 0.0035% | $1.64 | $14,834 | -9.15% | ||
| 2023-08-24 | Sale | Chief Operating Officer | 5,388 0.0021% | $1.64 | $8,836 | -9.15% | ||
| 2023-08-18 | Sale | President and CEO | 55,855 0.0225% | $1.66 | $92,719 | -13.66% | ||
| 2023-08-17 | Sale | SVP, IP Affairs | 8,741 0.0031% | $1.55 | $13,549 | -19.18% | ||
| 2023-08-17 | Sale | Chief Legal Officer | 10,762 0.0038% | $1.55 | $16,681 | -19.18% | ||
| 2023-08-17 | Sale | Chief Financial Officer | 8,893 0.0031% | $1.55 | $13,784 | -19.18% | ||
| 2023-08-17 | Sale | Chief Operating Officer | 5,298 0.0019% | $1.55 | $8,212 | -19.18% | ||
| 2023-08-16 | 119,411 0.0466% | $1.51 | $180,311 | -8.38% | ||||
| 2023-08-15 | 380,589 0.1477% | $1.52 | $577,301 | -8.82% | ||||
| 2023-08-14 | director | 400,000 0.1622% | $1.72 | $688,000 | -15.96% | |||
| 2023-08-14 | director | 570,345 0.2353% | $1.75 | $998,104 | -15.96% | |||
| 2023-08-11 | Sale | President and CEO | 41,436 0.0152% | $1.44 | $59,668 | -9.25% |
Insider Historical Profitability
| KIRK RANDAL J | 64547214 22.0396% | $0.76 | 70 | 12 | +7.38% | |
| Perez Jeffrey Thomas | SVP, IP Affairs | 743097 0.2537% | $0.76 | 3 | 20 | <0.0001% |
| KINDLER JEFFREY B | director | 238275 0.0814% | $0.76 | 2 | 2 | <0.0001% |
| Ares Trading S.A. | 10 percent owner | 20647152 7.05% | $0.76 | 1 | 67 | +52.74% |
| Sabzevari Helen | President and CEO | 1560004 0.5327% | $0.76 | 1 | 23 | <0.0001% |
Institutional Investor Ownership
| Patient Capital Management Llc | $25.31M | 6.91 | 17.45M | +9.2% | +$2.13M | 1.23 | |
| BlackRock | $15.03M | 4.11 | 10.36M | -6.81% | -$1.1M | <0.0001 | |
| The Vanguard Group | $9.81M | 2.68 | 6.77M | +0.29% | +$28,818.75 | <0.0001 | |
| Geode Capital Management | $4.4M | 1.2 | 3.03M | +0.32% | +$13,904.17 | <0.0001 | |
| State Street | $4.1M | 1.12 | 2.83M | +5.25% | +$204,329.67 | <0.0001 |